Search Results - "YANG, TIANBING"
-
1
Combined Therapy Using Human Corneal Stromal Stem Cells and Quiescent Keratocytes to Prevent Corneal Scarring after Injury
Published in International journal of molecular sciences (01-07-2022)“…Corneal blindness due to scarring is conventionally treated by corneal transplantation, but the shortage of donor materials has been a major issue affecting…”
Get full text
Journal Article -
2
Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p – A robust cell selection tool for stem cell therapy of corneal scarring
Published in Journal of advanced research (01-03-2023)“…A schematic overview of this study showing corneal stromal stem cell (CSSC) isolation from anterior limbal stromal tissue, ex vivo cell culture, extraction of…”
Get full text
Journal Article -
3
Pericytes reduce inflammation and collagen deposition in acute wounds
Published in Cytotherapy (Oxford, England) (01-08-2018)“…Abstract Background Pericytes have been shown to have mesenchymal stromal cell–like properties and play a role in tissue regeneration. The goal of this study…”
Get full text
Journal Article -
4
The anti-scarring effect of corneal stromal stem cell therapy is mediated by transforming growth factor β3
Published in Eye and vision (Novato, Calif.) (03-11-2020)“…Abstract Background Corneal stromal stem cells (CSSC) reduce corneal inflammation, prevent fibrotic scarring, and regenerate transparent stromal tissue in…”
Get full text
Journal Article -
5
Induction of CCL20 production by Kaposi sarcoma–associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-κB activation
Published in Blood (28-05-2009)“…Kaposi sarcoma–associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent of Kaposi sarcoma (KS), an angioproliferative lesion…”
Get full text
Journal Article -
6
K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis
Published in PloS one (24-10-2007)“…Accumulating evidence suggests that dysregulated expression of lytic genes plays an important role in KSHV (Kaposi's sarcoma associated herpesvirus)…”
Get full text
Journal Article -
7
Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: Implications for the use of dendritic cells for therapy of gliomas
Published in Cancer research (Chicago, Ill.) (01-05-2002)“…As a means of enhancing immunity to gliomas, we investigated local delivery of rat, bone marrow-derived dendritic cells (DCs) into rat 9L gliosarcoma tumors…”
Get full text
Journal Article -
8
Cyclooxygenase-2 Inhibition for the Prevention of Subglottic Stenosis
Published in Archives of otolaryngology--head & neck surgery (01-10-2012)“…OBJECTIVE To evaluate the role of targeted cyclooxygenase-2 inhibition in reducing scarring associated with a subglottic airway mucosal injury. DESIGN…”
Get full text
Journal Article -
9
Kaposi's Sarcoma-associated Herpesvirus (KSHV) Oncoprotein K13 Bypasses TRAFs and Directly Interacts with the IκB Kinase Complex to Selectively Activate NF-κB without JNK Activation
Published in The Journal of biological chemistry (24-08-2007)“…Kaposi's sarcoma herpesvirus oncoprotein vFLIP K13 is a potent activator of NF-κB and plays a key role in viral pathogenesis. K13 contains a putative…”
Get full text
Journal Article -
10
The anti-scarring effect of corneal stromal stem cell therapy is mediated by transforming growth factor [beta]3
Published in Eye and vision (Novato, Calif.) (03-11-2020)“…Background Corneal stromal stem cells (CSSC) reduce corneal inflammation, prevent fibrotic scarring, and regenerate transparent stromal tissue in injured…”
Get full text
Journal Article -
11
Abstract 41: DIFFERENTIAL INFLAMMATORY SIGNALING AND SYNTHESIS OF COLLAGEN AND FIBRONECTIN BY ADIPOSE STEM CELLS AND FIBROBLASTS OF DIFFERENT PHENOTYPES RELEVANT TO OUTCOME OF CELL-BASED WOUND THERAPIES
Published in Plastic and reconstructive surgery (1963) (01-05-2013)Get full text
Journal Article -
12
Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies
Published in Investigational new drugs (01-08-2012)“…Summary Background Combined inhibition of epidermal growth factor receptor (EGFR) and Src family kinases (SFK) may lead to improved therapeutic effects. We…”
Get full text
Journal Article -
13
Kaposi's Sarcoma-associated Herpesvirus (KSHV) Oncoprotein K13 Bypasses TRAFs and Directly Interacts with the IκB Kinase Complex to Selectively Activate NF-κB without JNK Activation
Published in The Journal of biological chemistry (24-08-2007)“…Kaposi's sarcoma herpesvirus oncoprotein vFLIP K13 is a potent activator of NF-κB and plays a key role in viral pathogenesis. K13 contains a putative…”
Get full text
Journal Article -
14
Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation
Published in The Journal of biological chemistry (24-08-2007)“…Kaposi's sarcoma herpesvirus oncoprotein vFLIP K13 is a potent activator of NF-kappaB and plays a key role in viral pathogenesis. K13 contains a putative…”
Get full text
Journal Article -
15
Effect of Nimesulide and PGE2 Therapy, Alone and in Combination, in a Cutaneous Wound Model in Rats
Published in The Laryngoscope (2009)Get full text
Journal Article -
16
CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture
Published in Immunologic research (01-01-2006)“…Co-culture of natural killer (NK) cells and dendritic cells (DCs) results in their reciprocal co-activation, and an enhancement of lysis of tumor target cells…”
Get full text
Journal Article -
17
Expression of a soluble transforming growth factor-[beta] (TGF[beta]) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo
Published in Journal of neuro-oncology (01-08-2003)“…Immunotherapy of gliomas has been forwarded as an attractive alternative to standard therapeutic modalities. Numerous observations indicate some therapeutic…”
Get full text
Journal Article -
18
Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo
Published in Journal of neuro-oncology (01-08-2003)“…Immunotherapy of gliomas has been forwarded as an attractive alternative to standard therapeutic modalities. Numerous observations indicate some therapeutic…”
Get full text
Journal Article -
19
Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation
Published in Blood (28-05-2009)“…Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent of Kaposi sarcoma (KS), an angioproliferative lesion…”
Get full text
Journal Article -
20